ANIX News and Press, Anixa Biosciences Inc. From 10/26/21

Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study - Cleveland Clinic conducting Phase 1 trial - PR Newswire SAN JOSE, Calif. and CLEVELAND , Oct. 26, 202...

Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technology PR Newswire SAN JOSE, Calif. , Oct. 6, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevent...

Anixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy PR Newswire SAN JOSE, Calif. , Oct. 1, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment an...

Today, we take an in-depth look at Anixa Biosciences, a small developmental firm on the west coast. The company's pipeline has multiple 'shots on goal' including one candidate that has shown some early analytical potential promise against the Covid-19 Delta variant. A full analysi...

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium PR Newswire SAN JOSE, Calif. , Sept. 14, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company ...

Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire SAN JOSE, Calif. , Sept. 8, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention ...

Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer PR Newswire SAN JOSE, Calif. , Sept. 7, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infec...

Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapy PR Newswire SAN JOSE, Calif. , Aug. 30, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company fo...

Anixa Biosciences' Covid-19 Compounds Expected to be Effective Against the Delta Variant PR Newswire SAN JOSE, Calif. , Aug. 25, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of ca...

Anixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer Initiative PR Newswire SAN JOSE, Calif. , Aug. 23, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused ...